XTX Topco Ltd

Position in SVRA — Savara Inc

CIK 1828301 LONDON, X0

Position in SVRA

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$754,661

-$1,316,873 QoQ

Shares Held

122,510

-67.7% QoQ

Ownership

0.060%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#72

of 181 holders

Holding Since

Jun 2021

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

XTX Topco Ltd holds $413,155,276 across 381 Biotechnology names. SVRA ranks #143 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	30,522	$19,031,687
2	ASND	Ascendis Pharma A/S	43,289	$11,546,042
3	BBIO	BridgeBio Pharma, Inc.	116,611	$8,685,187
4	MRNA	Moderna, Inc.	123,281	$8,633,368
5	JAZZ	Jazz Pharmaceuticals plc	30,496	$7,348,621
6	KYMR	Kymera Therapeutics, Inc.	61,501	$7,052,319
7	CYTK	Cytokinetics Inc	80,743	$6,878,496
8	PTCT	Ptc Therapeutics, Inc.	81,923	$6,682,459

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$754,661	122,510	-67.7%	Shares	Defined	2026-08-14
2026-03-31	$2,071,534	379,402	+1437.3%	Shares	Defined	2026-05-15
2025-12-31	$148,820	24,680	-36.2%	Shares	Defined	2026-02-17
2025-09-30	$138,041	38,667	-56.1%	Shares	Defined	2025-11-14
2025-06-30	$200,861	88,097	+691.1%	Shares	Defined	2025-08-12
2024-12-31	$34,187	11,136	-72.9%	Shares	Defined	2025-02-13
2024-06-30	$165,467	41,059	+289.1%	Shares	Defined	2024-08-12
2024-03-31	$52,543	10,551	-16.8%	Shares	Defined	2024-05-13
2023-06-30	$40,496	12,675	-35.2%	Shares	Defined	2023-08-14
2021-12-31	$24,258	19,563	-17.5%	Shares	Defined	2022-02-11
2021-09-30	$32,717	23,708	-64.4%	Shares	Defined	2021-11-12
2021-06-30	$113,133	66,549	—	Shares	Defined	2021-08-12
No filing history on record for this holder in this stock.